Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation

BACKGROUND: High-dose, post-transplantation cyclophosphamide (PTCy) to prevent graft-versus-host disease (GVHD) has improved outcomes in haploidentical (HAPLO) stem cell transplantation (SCT). However, it remains unclear whether this strategy is effective in SCT from 1-antigen human leukocyte antige...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Gaballa, Sameh, Ge, Isabell, Fakih, Riad El, Brammer, Jonathan E., Kongtim, Piyanuch, Tomuleasa, Ciprian, Wang, Sa A., Lee, Dean, Petropoulos, Demetrios, Cao, Kai, Rondon, Gabriela, Chen, Julianne, Hammerstrom, Aimee, Lombardi, Lindsey, Alatrash, Gheath, Korbling, Martin, Oran, Betul, Kebriaei, Partow, Ahmed, Sairah, Shah, Nina, Rezvani, Katayoun, Marin, David, Bashir, Qaiser, Alousi, Amin, Nieto, Yago, Qazilbash, Muzaffar, Hosing, Chitra, Popat, Uday, Shpall, Elizabeth J., Khouri, Issa, Champlin, Richard E., Ciurea, Stefan O.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459484/
https://ncbi.nlm.nih.gov/pubmed/27404668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30180
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky